- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharma secures USFDA final approval for Triamcinolone Acetonide Injectable Suspension. This strengthens its portfolio in autoimmune/inflammatory drugs, tapping into an estimated annual market of US$96 million (~₹800 Cr). Positive business development.